Aprogen Biologics Inc. (KRX:003060)

Market Cap	229.20B
Revenue (ttm)	67.38B
Net Income (ttm)	-104.98B
Shares Out	310.99M
EPS (ttm)	-835.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	264,461
Average Volume	482,498
Open	737.00
Previous Close	737.00
Day's Range	722.00 - 748.00
52-Week Range	600.00 - 1,900.00
Beta	0.14
RSI	50.72
Earnings Date	May 13, 2025

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-vira...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 377
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003060

Financial Performance

In 2024, Aprogen Biologics's revenue was 67.38 billion, a decrease of -22.88% compared to the previous year's 87.36 billion. Losses were -104.98 billion, -11.24% less than in 2023.